Clinical Studies of Human Cancer Treatment
Pp. 107-116 (10)
A.K.M. Shamsuddin and Guang-Yu Yang
Despite compelling experimental evidence of the efficacy of InsP6 + inositol
as an anticancer cocktail, there has been very limited enthusiasm for clinical studies of
cancer prevention and/or therapy. Notwithstanding this lack of interest, results from the
handful of clinical studies are extremely encouraging. Myo-inositol with or without
InsP6 has shown to be effective in preventing precancerous lesions of lung cancer.
Experimentally, InsP6 acts synergistically with standard chemotherapeutic drugs such as
doxorubicin and tamoxifen; emerging clinical data support that. InsP6 + inositol
available as dietary supplement has been reported to cause abrogation of breast, lung
and colorectal cancers, with or without standard therapies; reduce chemotherapyinduced
negative side-effects and provide a better quality of life.
Alopecia, beta-glucan, breast cancer, chemotherapy, colon cancer,
lung cancer, polychemotherapy, quality of life, radiotherapy.
The University of Maryland School of Medicine 10 S. Pine Street, MSTF-700 Baltimore, MD 21201-1116 USA., Northwestern University Feinberg School of Medicine 303 E Chicago Ave, Ward 4-115 Chicago, IL 60611 USA.